Neurogene Inc. (NGNE) Institutional Ownership

Ownership Summary

Neurogene Inc. (NASDAQ:NGNE) has 92 institutional investors that have filed 13F reports for the period ending December 2025.

• Their combined ownership stood at 78.1% of outstanding shares in December 2025, up from 72.4% in September 2025.
• Their total shares held in NGNE increased 9.95% from the prior quarter, while the number of investors in Neurogene increased 3.37% year over year.
• Among the 92 funds, 38 bought more Neurogene shares, 30 sold down, and 24 held their ground.
• In total, institutional investors held 16.54Mn shares in Neurogene as of December 2025, up by 1.5Mn shares quarter on quarter, and down 41.58K shares year over year.
• As of December 31, 2025, the biggest holder of Neurogene is Samsara BioCapital, LLC at 1.72Mn shares, representing 8.11% of shares outstanding.
• Top purchasers of NGNE stock for the quarter ending December 2025 included VANGUARD CAPITAL MANAGEMENT LLC (514.73K), FMR LLC (252.32K), GREAT POINT PARTNERS LLC (150.0K), MILLENNIUM MANAGEMENT LLC (133.49K), Casdin Capital, LLC (125.0K).
• The largest sellers of Neurogene for the quarter ending December 2025 were Goldman Sachs Group Inc (216.32K), Morgan Stanley (85.94K), ArrowMark Colorado Holdings LLC (52.69K), Bank Of America Corp /De/ (30.9K), Barclays Plc (12.62K).
• Business Quant data shows the 10 biggest positions in Neurogene as of December 2025 are held by Samsara BioCapital, LLC (1.72Mn), Redmile Group, LLC (1.46Mn), Casdin Capital, LLC (1.42Mn), RTW INVESTMENTS, LP (1.36Mn), EcoR1 Capital, LLC (1.27Mn), BlackRock, Inc. (1.01Mn), BAKER BROS. ADVISORS LP (991.69K), Trails Edge Capital Partners, LP (782.79K), BALYASNY ASSET MANAGEMENT L.P. (718.39K), Toronto Dominion Bank (681.34K).